Home >  News >  Industry >  Pharma News >  Siemens Healthineers,...

Siemens Healthineers, IISc and 2 others collaborate to advance healthcare innovation in India

By - Ruchika Sharma
Published On 2022-09-09 04:30 GMT   |   Update On 2022-09-09 11:10 GMT
Advertisement

Bangalore: As part of its enduring commitment to advancing healthcare with technology innovation in India, Siemens Healthineers has announced strategic partnerships with the Indian Institute of Science (IISc), HealthCare Global Enterprises Ltd (HCG), and Narayana Health (NH).

"These partnerships are big steps in making India an innovation center for Siemens Healthineers globally. The company continues to build on its committed investment of INR 1,300 crores (€160 million) to establish a new campus housing research and development, manufacturing, and sales, and an innovation center," the release stated.
"India is a strategic market for Siemens Healthineers and it plays an important role in global innovation and technology expansion to achieve the future of healthcare," says Peter Schardt, chief technology officer, Siemens Healthineers. "The partnerships will build on our focus towards fighting the mostthreatening diseases, enabling efficient operations, and expanding access to patient care. Through these collaborations, we strive to make healthcare even more efficient, sustainable, and humane for everyone across the country."
Advertisement
Dileep Mangsuli, Development Center head, Siemens Healthineers, says, "These partnerships reflect our commitment to India, bringing together innovation, education, healthcare, and talent to strengthen India's healthcare infrastructure and deliver the right treatment at the right time everywhere."

Speaking about the partnership, Prof. Govindan Rangarajan, Director, IISc said, "As IISc is opening up a new frontier of clinical research with the establishment of the IISc Medical School and Bagchi-Parathasarathy Hospital, this partnership with Siemens Healthineers will strengthen our focus in integrating science, engineering and medicine. This partnership will also enable our researchers to invent technologies for better and affordable healthcare outcomes."

Dr Devi Prasad Shetty, chairman and senior consultant cardiac surgeon, NH, commented, "We look forward to collaborating with Siemens Healthineers to advance the digitalization of healthcare and expand access to care, especially for cardiac patients."
Dr Ajaikumar BS, executive chairman, radiation & medical oncologist, HCG, added, "HCG has a long and cherished association with Siemens Healthineers. With this partnership, we will work towards further enhancing the quality and impact of cancer care for the community at large, as well as developing fellowship programs to advance research and academics in the oncology space. For me, it's another step towards realizing my vision of establishing a benchmark of high-end care across cancer care centers in India and the emerging markets."
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Roche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular dystrophy

Expert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First

Menopause relief drug: USFDA extends review period for Bayer Elinzanetant

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease

Troikaa's Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More Data

Sanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma

Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed

GSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma